Exforge is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Amlodipine Besylate; Valsartan.
| Product ID | 0078-0490_16f31180-e5cf-4747-95a8-2d0fd218a9b6 |
| NDC | 0078-0490 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Exforge |
| Generic Name | Amlodipine Besylate And Valsartan |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-06-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021990 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | AMLODIPINE BESYLATE; VALSARTAN |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2007-06-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021990 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-06-20 |
| Marketing End Date | 2011-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021990 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-06-20 |
| Marketing Category | NDA |
| Application Number | NDA021990 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-06-19 |
| Marketing End Date | 2015-08-11 |
| Marketing Category | NDA |
| Application Number | NDA021990 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-05-20 |
| Marketing End Date | 2011-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021990 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-06-20 |
| Marketing End Date | 2014-06-19 |
| Ingredient | Strength |
|---|---|
| AMLODIPINE BESYLATE | 5 mg/1 |
| SPL SET ID: | d0caec89-96ec-411d-a933-63eda74a6da7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0488 | Exforge | amlodipine besylate and valsartan |
| 0078-0489 | Exforge | amlodipine besylate and valsartan |
| 0078-0490 | Exforge | amlodipine besylate and valsartan |
| 0078-0491 | Exforge | amlodipine besylate and valsartan |
| 0781-5615 | AMLODIPINE AND VALSARTAN | amlodipine besylate and valsartan |
| 0781-5628 | AMLODIPINE AND VALSARTAN | amlodipine besylate and valsartan |
| 0781-5639 | AMLODIPINE AND VALSARTAN | amlodipine besylate and valsartan |
| 0781-5643 | AMLODIPINE AND VALSARTAN | amlodipine besylate and valsartan |
| 50090-2471 | AMLODIPINE AND VALSARTAN | amlodipine besylate and valsartan |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EXFORGE 98663627 not registered Live/Pending |
Hangzhou Jizhu E-commerce Co., Ltd. 2024-07-24 |
![]() EXFORGE 78905845 3490550 Live/Registered |
Novartis AG 2006-06-12 |
![]() EXFORGE 78089458 2764146 Live/Registered |
Novartis AG 2001-10-22 |